Publication: Evaluation of commercially available anti-dengue virus immunoglobulin M tests
| dc.contributor.author | Elizabeth A. Hunsperger | en_US |
| dc.contributor.author | Sutee Yoksan | en_US |
| dc.contributor.author | Philippe Buchy | en_US |
| dc.contributor.author | Vinh Chau Nguyen | en_US |
| dc.contributor.author | Shamala D. Sekaran | en_US |
| dc.contributor.author | Delia A. Enria | en_US |
| dc.contributor.author | Jose L. Pelegrino | en_US |
| dc.contributor.author | Susana Vázquez | en_US |
| dc.contributor.author | Harvey Artsob | en_US |
| dc.contributor.author | Michael Drebot | en_US |
| dc.contributor.author | Duane J. Gubler | en_US |
| dc.contributor.author | Scott B. Halstead | en_US |
| dc.contributor.author | María G. Guzmán | en_US |
| dc.contributor.author | Harold S. Margolis | en_US |
| dc.contributor.author | Carl Michael Nathanson | en_US |
| dc.contributor.author | Nidia R Rizzo Lic | en_US |
| dc.contributor.author | Kovi E. Bessoff | en_US |
| dc.contributor.author | Srisakul Kliks | en_US |
| dc.contributor.author | Rosanna W. Peeling | en_US |
| dc.contributor.other | Centers for Disease Control and Prevention San Juan | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.contributor.other | Institut Pasteur du Cambodge | en_US |
| dc.contributor.other | Cho Quan Hospital | en_US |
| dc.contributor.other | University of Malaya | en_US |
| dc.contributor.other | Instituto Nacional de Enfermedades Virales Humanas Dr. Julio I. Maiztegui | en_US |
| dc.contributor.other | Instituto de Medicina Tropical Pedro Kouri | en_US |
| dc.contributor.other | Agence de la sante publique du Canada | en_US |
| dc.contributor.other | University of Hawaii at Manoa | en_US |
| dc.contributor.other | Pediatric Dengue Vaccine Initiative | en_US |
| dc.contributor.other | Organisation Mondiale de la Sante | en_US |
| dc.date.accessioned | 2018-09-13T07:05:09Z | |
| dc.date.available | 2018-09-13T07:05:09Z | |
| dc.date.issued | 2009-03-01 | en_US |
| dc.description.abstract | Anti-dengue virus immunoglobulin M kits were evaluated. Test sensitivities were 21%-99% and specificities were 77%-98% compared with reference ELISAs. False-positive results were found for patients with malaria or past dengue infections. Three ELISAs showing strong agreement with reference ELISAs will be included in the World Health Organization Bulk Procurement Scheme. | en_US |
| dc.identifier.citation | Emerging Infectious Diseases. Vol.15, No.3 (2009), 436-440 | en_US |
| dc.identifier.doi | 10.3201/eid1503.080923 | en_US |
| dc.identifier.issn | 10806059 | en_US |
| dc.identifier.issn | 10806040 | en_US |
| dc.identifier.other | 2-s2.0-63849340687 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/28186 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=63849340687&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Evaluation of commercially available anti-dengue virus immunoglobulin M tests | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=63849340687&origin=inward | en_US |